Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Refractory Solid Tumors × verubulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasm Metastasis 2 Glioblastoma 2 Brain Neoplasms 2 Refractory Solid Tumors 1 Recurrence 1 Melanoma 1

Interventions

Sorafenib 3 pazopanib 2 verubulin 1 trifluridine tipiracil drug combination 1 irinotecan sucrosofate 1 eribulin 1 Valproic Acid 1 Temozolomide 1 Sunitinib 1 Sirolimus 1 Irinotecan 1 Interleukin-27 1 Hydralazine 1 Erlotinib Hydrochloride 1 Azurin 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00394446 2008-02-13

Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors

Myrexis Inc.

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡